Related references
Note: Only part of the references are listed.Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study
Birgitte Klug Albertsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen
Trevor N. Christ et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2018)
Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia A Review
Stuart E. Siegel et al.
JAMA ONCOLOGY (2018)
Experience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity
Chintan Vyas et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2018)
In Vivo Imaging of Antileukemic Drug Asparaginase Reveals a Rapid Macrophage-Mediated Clearance from the Bone Marrow
Laurens T. van der Meer et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial
B. Patel et al.
LEUKEMIA (2017)
Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation
Louise Tram Henriksen et al.
PEDIATRIC BLOOD & CANCER (2017)
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation
Inge M. van der Sluis et al.
HAEMATOLOGICA (2016)
Allergic reactions associated with pegaspargase in adults
Abraham Chang et al.
LEUKEMIA & LYMPHOMA (2016)
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation
Inge M. van der Sluis et al.
HAEMATOLOGICA (2016)
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
Andrew E. Place et al.
LANCET ONCOLOGY (2015)
A germ line mutation in cathepsin B points toward a role in asparaginase pharmacokinetics
Laurens T. van der Meer et al.
BLOOD (2014)
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia
Wing H. Tong et al.
BLOOD (2014)
The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells
Wai Kin Chan et al.
BLOOD (2014)
Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia
Dan Douer et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group
Wanda L. Salzer et al.
BLOOD (2013)
Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study-Dana-Farber Cancer Institute ALL Consortium Protocol 00-01
Lynda M. Vrooman et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
Nicola Goekbuget et al.
BLOOD (2012)
Asparaginase in the management of adult acute lymphoblastic leukaemia: Is it used appropriately?
Sushrut Patil et al.
CANCER TREATMENT REVIEWS (2011)
Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel
Wendy Stock et al.
LEUKEMIA & LYMPHOMA (2011)
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia
C. H. Pui et al.
LEUKEMIA (2010)
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
A. Moericke et al.
LEUKEMIA (2010)
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia
V. Conter et al.
LEUKEMIA (2010)
Pegasparaginase: where do we stand?
Amer Zeidan et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice
Seema R. Patel et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
Francoise Huguet et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock et al.
BLOOD (2008)
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511
Meir Wetzler et al.
BLOOD (2007)
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia
Albert Moghrabi et al.
BLOOD (2007)
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia
A Pession et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations - The past, the present and recommendations for the future
VI Avramis et al.
CLINICAL PHARMACOKINETICS (2005)
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia - Children's Cancer Group Study CCG-1961
EH Panosyan et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?: Comparison of the French FRALLE-93 and LALA-94 trials
N Boissel et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Pegylated asparaginase in combination with high-dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study
O Rosen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum
C Lanvers et al.
ANALYTICAL BIOCHEMISTRY (2002)
Share Paper
